The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST): Questions and Answers

ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol


Media Type: Html

Tags

General: treatment trial drug screening lung tumor genetic gene marker mutation ALK EGFR survival ALCHEMIST

Preview   0 Users liked this content.

Embed Code Snippet


To get the embed code snippet please Login.